Logos Global Management LP Beam Therapeutics Inc. Transaction History
Logos Global Management LP
- $756 Million
- Q3 2024
A detailed history of Logos Global Management LP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Logos Global Management LP holds 500,000 shares of BEAM stock, worth $13.9 Million. This represents 1.62% of its overall portfolio holdings.
Number of Shares
500,000Holding current value
$13.9 Million% of portfolio
1.62%Shares
1 transactions
Others Institutions Holding BEAM
# of Institutions
238Shares Held
76.2MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$228 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$218 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$212 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$197 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$135 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.96B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...